PMAQX has more cash in the bank: 23.8B vs. CLSDX (2.3B). CLSDX (0.00) and PMAQX (0.00) have matching dividends . CLSDX was incepted earlier than PMAQX: CLSDX (2 years) vs PMAQX (10 years). CLSDX (0.88) is less costly to investors than PMAQX (0.57). CLSDX is a more actively managed with annual turnover of: 200.00 vs. PMAQX (13.70). CLSDX (0) and PMAQX (0) have matching initial minimum investment requirements. CLSDX annual gain was more profitable for investors over the last year : 6.61 vs. PMAQX (-9.47).

	CLSDX	PMAQX	CLSDX / PMAQX
Total Expense Ratio	0.87	0.57	153%
Annual Report Gross Expense Ratio	0.88	0.57	154%
Fund Existence	2 years	10 years	-
Gain YTD	18.648	-0.816	-2,286%
Front Load	N/A	N/A	-
Min. Initial Investment	0	0	-
Min. Initial Investment IRA	N/A	N/A	-
Net Assets	2.3B	23.8B	10%
Annual Yield % from dividends	0.00	0.00	-
Returns for 1 year	6.61	-9.47	-70%
Returns for 3 years	N/A	18.33	-
Returns for 5 years	N/A	-0.02	-
Returns for 10 years	N/A	N/A	-

View a ticker or compare two or three

Ask AI

Compare

Interact to see
Advertisement

Interesting Tickers

ETFs / NAME	Price $	Chg $	Chg %
		1 Day
KIQQ	25.13	0.19	+0.75%
KraneSharesInspereXNasdaqDynBfrdHInIdETF
PJP	125.45	0.60	+0.48%
Invesco Pharmaceuticals ETF
CPRY	28.16	-0.01	-0.05%
Calamos Russell 2000 Str Alt Prt ETF-Jan
IBDV	21.58	-0.06	-0.25%
iShares iBonds Dec 2030 Term Corp ETF
IZRL	29.77	-0.19	-0.63%
ARK Israel Innovative Technology ETF